aluates Reports

$ 0.0

Automative

Respiratory Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-5L12151

Global Respiratory Drugs Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Respiratory Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5L12151

Report

September 2024

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

FibroGen Inc

Amgen Inc

Dr. Reddy’s Laboratories

Afferent Pharmaceuticals

Dainippon Sumitomo

Abbott

Horizon Pharma

Pfizer Inc

Respiratory Drugs - Market Size

The global market for Respiratory Drugs was estimated to be worth US$ 43040 million in 2023 and is forecast to a readjusted size of US$ 64390 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Respiratory Drugs - Market

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Respiratory Drugs by region & country, by Type, and by Application.

The Respiratory Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Drugs.

Market Segmentation

Scope of Respiratory Drugs - Market Report

Report Metric	Details
Report Name	Respiratory Drugs - Market
Forecasted market size in 2030	US$ 64390 million
CAGR	5.8%
Forecasted years	2024 - 2030
Segment by Type:	Asthma Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis Cystic Fibrosis
Segment by Application	Hospitals Ambulatory Care Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	FibroGen, Amgen, Dr. Reddy's Laboratories, Afferent Pharmaceuticals, Dainippon Sumitomo, Abbott, Horizon Pharma, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Respiratory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Respiratory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Respiratory Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Respiratory Drugs - Market size in 2030?

Ans: The Respiratory Drugs - Market size in 2030 will be US$ 64390 million.

Who are the main players in the Respiratory Drugs - Market report?

Ans: The main players in the Respiratory Drugs - Market are FibroGen, Amgen, Dr. Reddy's Laboratories, Afferent Pharmaceuticals, Dainippon Sumitomo, Abbott, Horizon Pharma, Pfizer

What are the Application segmentation covered in the Respiratory Drugs - Market report?

Ans: The Applications covered in the Respiratory Drugs - Market report are Hospitals, Ambulatory Care, Others

What are the Type segmentation covered in the Respiratory Drugs - Market report?

Ans: The Types covered in the Respiratory Drugs - Market report are Asthma, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis

Recommended Reports

Asthma & Allergy

Pulmonary Disease

Virus & Infection

1 Market Overview

1.1 Respiratory Drugs Product Introduction

1.2 Global Respiratory Drugs Market Size Forecast

1.2.1 Global Respiratory Drugs Sales Value (2019-2030)

1.2.2 Global Respiratory Drugs Sales Volume (2019-2030)

1.2.3 Global Respiratory Drugs Sales Price (2019-2030)

1.3 Respiratory Drugs Market Trends & Drivers

1.3.1 Respiratory Drugs Industry Trends

1.3.2 Respiratory Drugs Market Drivers & Opportunity

1.3.3 Respiratory Drugs Market Challenges

1.3.4 Respiratory Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Respiratory Drugs Players Revenue Ranking (2023)

2.2 Global Respiratory Drugs Revenue by Company (2019-2024)

2.3 Global Respiratory Drugs Players Sales Volume Ranking (2023)

2.4 Global Respiratory Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Respiratory Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Respiratory Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Respiratory Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Respiratory Drugs

2.9 Respiratory Drugs Market Competitive Analysis

2.9.1 Respiratory Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Respiratory Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Asthma

3.1.2 Chronic Obstructive Pulmonary Disease

3.1.3 Idiopathic Pulmonary Fibrosis

3.1.4 Cystic Fibrosis

3.2 Global Respiratory Drugs Sales Value by Type

3.2.1 Global Respiratory Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Respiratory Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Respiratory Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Respiratory Drugs Sales Volume by Type

3.3.1 Global Respiratory Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Respiratory Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Respiratory Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Respiratory Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Ambulatory Care

4.1.3 Others

4.2 Global Respiratory Drugs Sales Value by Application

4.2.1 Global Respiratory Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Respiratory Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Respiratory Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Respiratory Drugs Sales Volume by Application

4.3.1 Global Respiratory Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Respiratory Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Respiratory Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Respiratory Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Respiratory Drugs Sales Value by Region

5.1.1 Global Respiratory Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Respiratory Drugs Sales Value by Region (2019-2024)

5.1.3 Global Respiratory Drugs Sales Value by Region (2025-2030)

5.1.4 Global Respiratory Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Respiratory Drugs Sales Volume by Region

5.2.1 Global Respiratory Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Respiratory Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Respiratory Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Respiratory Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Respiratory Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Respiratory Drugs Sales Value, 2019-2030

5.4.2 North America Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Respiratory Drugs Sales Value, 2019-2030

5.5.2 Europe Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Respiratory Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Respiratory Drugs Sales Value, 2019-2030

5.7.2 South America Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Respiratory Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Respiratory Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Respiratory Drugs Sales Value

6.2.1 Key Countries/Regions Respiratory Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Respiratory Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Respiratory Drugs Sales Value, 2019-2030

6.3.2 United States Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Respiratory Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Respiratory Drugs Sales Value, 2019-2030

6.4.2 Europe Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Respiratory Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Respiratory Drugs Sales Value, 2019-2030

6.5.2 China Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Respiratory Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Respiratory Drugs Sales Value, 2019-2030

6.6.2 Japan Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Respiratory Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Respiratory Drugs Sales Value, 2019-2030

6.7.2 South Korea Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Respiratory Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Respiratory Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Respiratory Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Respiratory Drugs Sales Value, 2019-2030

6.9.2 India Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Respiratory Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 FibroGen

7.1.1 FibroGen Company Information

7.1.2 FibroGen Introduction and Business Overview

7.1.3 FibroGen Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 FibroGen Respiratory Drugs Product Offerings

7.1.5 FibroGen Recent Development

7.2 Amgen

7.2.1 Amgen Company Information

7.2.2 Amgen Introduction and Business Overview

7.2.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Amgen Respiratory Drugs Product Offerings

7.2.5 Amgen Recent Development

7.3 Dr. Reddy's Laboratories

7.3.1 Dr. Reddy's Laboratories Company Information

7.3.2 Dr. Reddy's Laboratories Introduction and Business Overview

7.3.3 Dr. Reddy's Laboratories Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Dr. Reddy's Laboratories Respiratory Drugs Product Offerings

7.3.5 Dr. Reddy's Laboratories Recent Development

7.4 Afferent Pharmaceuticals

7.4.1 Afferent Pharmaceuticals Company Information

7.4.2 Afferent Pharmaceuticals Introduction and Business Overview

7.4.3 Afferent Pharmaceuticals Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Afferent Pharmaceuticals Respiratory Drugs Product Offerings

7.4.5 Afferent Pharmaceuticals Recent Development

7.5 Dainippon Sumitomo

7.5.1 Dainippon Sumitomo Company Information

7.5.2 Dainippon Sumitomo Introduction and Business Overview

7.5.3 Dainippon Sumitomo Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Dainippon Sumitomo Respiratory Drugs Product Offerings

7.5.5 Dainippon Sumitomo Recent Development

7.6 Abbott

7.6.1 Abbott Company Information

7.6.2 Abbott Introduction and Business Overview

7.6.3 Abbott Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Abbott Respiratory Drugs Product Offerings

7.6.5 Abbott Recent Development

7.7 Horizon Pharma

7.7.1 Horizon Pharma Company Information

7.7.2 Horizon Pharma Introduction and Business Overview

7.7.3 Horizon Pharma Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Horizon Pharma Respiratory Drugs Product Offerings

7.7.5 Horizon Pharma Recent Development

7.8 Amgen

7.8.1 Amgen Company Information

7.8.2 Amgen Introduction and Business Overview

7.8.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Amgen Respiratory Drugs Product Offerings

7.8.5 Amgen Recent Development

7.9 Pfizer

7.9.1 Pfizer Company Information

7.9.2 Pfizer Introduction and Business Overview

7.9.3 Pfizer Respiratory Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Pfizer Respiratory Drugs Product Offerings

7.9.5 Pfizer Recent Development

8 Industry Chain Analysis

8.1 Respiratory Drugs Industrial Chain

8.2 Respiratory Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Respiratory Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Respiratory Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

FibroGen Inc

Amgen Inc

Dr. Reddy’s Laboratories

Afferent Pharmaceuticals

Dainippon Sumitomo

Abbott

Horizon Pharma

Pfizer Inc

List of Tables

Table 1. Respiratory Drugs Market Trends

Table 2. Respiratory Drugs Market Drivers & Opportunity

Table 3. Respiratory Drugs Market Challenges

Table 4. Respiratory Drugs Market Restraints

Table 5. Global Respiratory Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Respiratory Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Respiratory Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Respiratory Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Respiratory Drugs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Respiratory Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Respiratory Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Respiratory Drugs

Table 13. Global Respiratory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Respiratory Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Respiratory Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Respiratory Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Respiratory Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Respiratory Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Respiratory Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Respiratory Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Respiratory Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Respiratory Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Respiratory Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Respiratory Drugs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Respiratory Drugs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Respiratory Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Respiratory Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Respiratory Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Respiratory Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Respiratory Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Respiratory Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Respiratory Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Respiratory Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Respiratory Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Respiratory Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Respiratory Drugs Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Respiratory Drugs Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Respiratory Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Respiratory Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Respiratory Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Respiratory Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Respiratory Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Respiratory Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Respiratory Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Respiratory Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Respiratory Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Respiratory Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Respiratory Drugs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Respiratory Drugs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Respiratory Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Respiratory Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Respiratory Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Respiratory Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Respiratory Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. FibroGen Company Information

Table 58. FibroGen Introduction and Business Overview

Table 59. FibroGen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. FibroGen Respiratory Drugs Product Offerings

Table 61. FibroGen Recent Development

Table 62. Amgen Company Information

Table 63. Amgen Introduction and Business Overview

Table 64. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Amgen Respiratory Drugs Product Offerings

Table 66. Amgen Recent Development

Table 67. Dr. Reddy's Laboratories Company Information

Table 68. Dr. Reddy's Laboratories Introduction and Business Overview

Table 69. Dr. Reddy's Laboratories Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Dr. Reddy's Laboratories Respiratory Drugs Product Offerings

Table 71. Dr. Reddy's Laboratories Recent Development

Table 72. Afferent Pharmaceuticals Company Information

Table 73. Afferent Pharmaceuticals Introduction and Business Overview

Table 74. Afferent Pharmaceuticals Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Afferent Pharmaceuticals Respiratory Drugs Product Offerings

Table 76. Afferent Pharmaceuticals Recent Development

Table 77. Dainippon Sumitomo Company Information

Table 78. Dainippon Sumitomo Introduction and Business Overview

Table 79. Dainippon Sumitomo Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Dainippon Sumitomo Respiratory Drugs Product Offerings

Table 81. Dainippon Sumitomo Recent Development

Table 82. Abbott Company Information

Table 83. Abbott Introduction and Business Overview

Table 84. Abbott Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Abbott Respiratory Drugs Product Offerings

Table 86. Abbott Recent Development

Table 87. Horizon Pharma Company Information

Table 88. Horizon Pharma Introduction and Business Overview

Table 89. Horizon Pharma Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Horizon Pharma Respiratory Drugs Product Offerings

Table 91. Horizon Pharma Recent Development

Table 92. Amgen Company Information

Table 93. Amgen Introduction and Business Overview

Table 94. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Amgen Respiratory Drugs Product Offerings

Table 96. Amgen Recent Development

Table 97. Pfizer Company Information

Table 98. Pfizer Introduction and Business Overview

Table 99. Pfizer Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Pfizer Respiratory Drugs Product Offerings

Table 101. Pfizer Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Respiratory Drugs Downstream Customers

Table 105. Respiratory Drugs Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Respiratory Drugs Product Picture

Figure 2. Global Respiratory Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Respiratory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Respiratory Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Respiratory Drugs Sales Price (2019-2030) & (USD/Unit)

Figure 6. Respiratory Drugs Report Years Considered

Figure 7. Global Respiratory Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Respiratory Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Drugs Revenue in 2023

Figure 10. Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Asthma Picture

Figure 12. Chronic Obstructive Pulmonary Disease Picture

Figure 13. Idiopathic Pulmonary Fibrosis Picture

Figure 14. Cystic Fibrosis Picture

Figure 15. Global Respiratory Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Respiratory Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Respiratory Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Respiratory Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Respiratory Drugs Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Hospitals

Figure 21. Product Picture of Ambulatory Care

Figure 22. Product Picture of Others

Figure 23. Global Respiratory Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Respiratory Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Respiratory Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Respiratory Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Respiratory Drugs Price by Application (2019-2030) & (USD/Unit)

Figure 28. North America Respiratory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Respiratory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Respiratory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Respiratory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Respiratory Drugs Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Respiratory Drugs Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Respiratory Drugs Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Respiratory Drugs Sales Volume (%), (2019-2030)

Figure 40. United States Respiratory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Respiratory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Respiratory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Respiratory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. China Respiratory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. China Respiratory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Respiratory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Respiratory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Respiratory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Respiratory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Respiratory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Respiratory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 58. India Respiratory Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Respiratory Drugs Sales Value by Type (%), 2023 VS 2030

Figure 60. India Respiratory Drugs Sales Value by Application (%), 2023 VS 2030

Figure 61. Respiratory Drugs Industrial Chain

Figure 62. Respiratory Drugs Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Respiratory Drug Market Research Report 2024

Global Human Respiratory Disease Treatment Market Research Report 2025

Respiratory Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Inhaler Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Asthma and COPD Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Treatment for Respiratory Disease Market Research Report 2024

Pulmonary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs for Respiratory Diseases Market Research Report 2024

Global Prescription Respiratory Drugs Market Research Report 2024

Drug Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Respiratory Diseases Treatment Market Insights Forecast to 2030

Chronic Obstructive Pulmonary Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Asthma and COPD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global COPD Drugs Market Research Report 2024

Global Respiratory Care Device Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Chronic Obstructive Pulmonary Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Expectorant Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions